Trick or treat: The effect of placebo on the power of pharmacogenetic association studies

Human Genomics

Volumn 2, Issue 1, 2005, Pages 28-38

  Singer, Clara ^a   Grossman, Iris ^a,b   Avidan, Nili ^a   Beckmann, Jacques S ^a,c   Pe'er, Itsik ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Haplotype; Power; Simulation; Single nucleotide polymorphism; Trial design

Indexed keywords

DRUG; PLACEBO;

ARTICLE; CALIBRATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG RESPONSE; EXPERIMENTAL DESIGN; GENETIC ASSOCIATION; GENETIC MARKER; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; PENETRANCE; PHARMACOGENETICS; POWER OF A TEST; RISK ASSESSMENT; SAMPLE SIZE; SIMULATION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; STATISTICAL PARAMETERS;

EID: 33646176438     PISSN: 14797364     EISSN: 14797364     Source Type: Journal    
DOI: 10.1186/1479-7364-2-1-28     Document Type: Article

References (33)

1. Roses, A.D. (2000), Pharmacogenetics and the practice of medicine', Nature Vol. 405, pp. 857-865.
2. Pirmohamed, M. and Park, B.K. (2001), 'Genetic susceptibility to adverse drug reactions', Trends Pharmacol. Sci. Vol. 22, pp. 298-305.
3. Lurcott, G. (1998), 'The effects ofthe genetic absence and inhibition of CYP2D6 on the metabolism of codeine and its derivatives, hydrocodone and oxycodone', Anesth. Prog. Vol. 45, pp. 154-156.
4. Arranz, M.J., Munro, J., Birkett, J. et al. (2000), 'Pharmacogenetic prediction of clozapine response', Lancet Vol. 355, pp. 1615-1616.
5. Morton, V and Torgerson, D.J. (2003), 'Effect of regression to the mean on decision making in health care', BMJ. Vol. 326, pp. 1083-1084.
6. Spiegel, D., Kraemer, H. and Carlson, R.W. (2001), 'Is the placebo powerless?', N. Engl. J. Med. Vol. 345, pp. 1276; author reply pp. 1278-1279.
7. Hrobjartsson, A. and Gotzsche, P.C. (2001), 'Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment', N. Engl. J. Med. Vol. 344, pp. 1594-1602.
8. Zondervan, K.T. and Cardon, L.R. (2004), 'The complex interplay among factors that influence allelic association', Nat. Rev. Genet. Vol. 5, pp. 89-100.
9. McGinnis, R., Shifman, S. and Darvasi, A. (2002), 'Power and efficiency of the TDT and case-control design for association scans', Behav. Genet. Vol. 32, pp. 135-144.
10. Long, A.D. and Langley, C.H. (1999), 'The power of association studies to detect the contribution of candidate genetic loci to variation in complex traits', Genome Res. Vol. 9, pp. 720-731.
11. Hudson, R.R. (1983), 'Properties of a neutral allele model with intergenic recombination', Theor. Popul. Biol. Vol. 23, pp. 183-201.
12. Cardon, L.R., Idury, R.M., Harris, T.J. (2000), 'Testing drug response in the presence of genetic information: Sampling issues for clinical trials', Pharmacogenetics Vol. 10, pp. 503-510.
13. Essebag, V., Genest, Jr., J., Suissa, S. et al. (2003), 'The nested case-control study in cardiology', Am. Heart J. Vol. 146, pp 581-590.
14. Ott, J. and Hoh, J. (2001), 'Statistical multilocus methods for disequilibrium analysis in complex traits', Hum. Mutat. Vol. 17, pp. 285-288.
15. Zee, R.Y., Hoh, J., Cheng, S. et al. (2002), 'Muld-locus interactions predict risk for post-PTCA restenosis: An approach to the genetic analysis of common complex disease', Pharmacogenomics J. Vol. 2, pp. 197-201.
16. Gauderman, W.J. (2002), 'Sample size requirements for matched case-control studies of gene-environment interaction', Stat. Med. Vol. 21, pp. 35-50.
17. Garner, C. and Slatkin, M. (2003), 'On selecting markets for association studies: patterns of linkage disequilibrium between two and three diallelic loci', Genet. Epidemiol. Vol. 24, pp. 57-67.
18. Clayton, D. (2001), 'Population association', in Balding, D.J., Bishop, M., Cannings, C. (eds), Handbook of Statistical Genetics, John Wiley and Sons, NewYork, NY, pp. 519-540.
19. Hudson, R.R. (2002), 'Generating samples under a Wright-Fisher neutral model of genetic variation', Bioinformatics Vol. 18, pp. 337-338.
20. Anon. (1999), 'The logistic procedure' chapter 39 in SAS/STAT User's Guide, Version 8, SAS Publishing, SAS Institute Inc Cary, NC, pp. 1903-2044.
21. Churchill, G.A. and Doerge, R.W. (1994), 'Empirical threshold values for quantitative trait mapping', Genetics Vol. 138, pp. 963-971.
22. McIntyre, L.M., Martin, E.R., Simonsen, K.L. et al. (2000), 'Circumventing multiple testing: A multilocus Monte Carlo approach to testing for association', Genet. Epidemiol. Vol. 19, pp. 18-29.
23. Stephens, M., Smith, N.J. and Donnelly, P. (2001), 'A new statistical method for haplotype reconstruction from population data', Am. J. Hum. Genet. Vol. 68, pp. 978-989.
24. Purcell, S., Cherny, S.S. and Sharn, P.C. (2003), 'Genetic Power Calculator: Design of linkage and association genetic mapping studies of complex traits', Bioinformatics Vol. 19, pp. 149-150.
25. Lander, E.S. (1996), 'The new genomics: Global views of biology', Science Vol, 274, pp. 536-539.
26. Pritchard, J.K. and Cox, N.J. (2002), 'The allelic architecture of human disease genes: Common disease-common variant... or not?', Hum. Mol. Genet. Vol. 11, pp, 2417-2423.
27. The International HapMap Consortium (2003), 'The International HapMap Project', Nature Vol. 426, pp. 789-796.
28. Templeton, A.R., Weiss, K.M., Nickerson, D.A. et al. (2000), 'Cladistic structure within the human lipoprotein lipase gene and its implications for phenotypic association studies', Genetics Vol. 156, pp. 1259-1275.
29. Barrett, J.C., Fry, B., Maller, J. et al. (2005), 'Haploview: Analysis and visualization of LD and haplotype maps', Bioinformatics Vol. 21, pp. 263-265.
30. Kaplan, N. and Morris, R. (2001), 'Issues concerning association studies for fine mapping a susceptibility gene for a complex disease', Genet. Epidemol. Vol. 20, pp. 432-457.
31. Templeton, A.R., Boerwinkle, E. and Sung, C.F. (1987), 'A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping. I. Basic theory and an analysis of alcohol dehydrogenase activity in Drosophila', Genetics Vol. 117, pp. 343-351.
32. Seltman, H., Roeder, K. and Devlin, B. (2003), 'Evolutionary-based association analysis using haplotype data', Genet. Epidemiol. Vol. 25, pp. 48-58.
33. Akey, J., Jin, L. and Xiong, M. (2001), 'Haplotypes vs single marker linkage disequilibrium tests: What do we gain?', Eur. J. Hum. Genet. Vol. 9, pp. 291-300.